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Overproduction of cytokines by T helper 2 (Th2) cells
in the lung is thought to be a cause of asthma. Here
we report that innate lymphocytes termed lung
natural helper (LNH) cells are a T cell-independent
source of Th2 cell-type cytokines in protease
allergen-treated lungs. LNH (LinSca-1+c-kit+/lo
CD25+CD127+) cells, when stimulated by IL-33 plus
IL-2, IL-7, or thymic stroma lymphopoietin (TSLP),
produced large amounts of IL-5 and IL-13. Intranasal
administration of protease allergen papain induced
eosinophil infiltration and mucus hyperproduction
in the lung of wild-type and Rag1/ mice, but not
in Rag2/Il2rg/ mice that lack LNH cells. LNH
cell depletion inhibited papain-induced airway
inflammation in Rag1/ mice whereas adoptive
transfer of LNH cells enabled Rag2/Il2rg/ mice
to respond to papain. Treatment of lung explants
with papain induced IL-33 and TSLP production by
stroma cells and IL-5 and IL-13 production by LNH
cells. Thus, LNH cells are critical for protease
allergen-induced airway inflammation.
INTRODUCTION
Asthma is a chronic inflammatory disease of the lower airways
characterized by recurrent airway obstruction and wheezing. It
is induced by allergen such as pollen, molds, and dust mites
aswell as air-borne irritants and infections. Asthma is a heteroge-
neous disease and includes allergic, nonallergic, and intrinsic
forms, of which allergic asthma is the most common form (Kim
et al., 2010). Allergic asthma is thought to be driven by T helper
2 (Th2) cell-type cytokines including IL-4, IL-5, and IL-13. IL-4
promotes the production of IgE by B cells and the expression
of vascular cell adhesion molecule-1 (VCAM-1) on endothelial
cells (Steinke and Borish, 2001). IL-5 induces eosinophil devel-
opment, recruitment to the lung, and activation (Hamelmann
and Gelfand, 2001). Activated eosinophils produce a broad
range of cytokines and chemokines and are a potent source ofthe lipid mediator leukotriene C4 and platelet-activating factor,
which induce mucus secretion and smooth muscle contraction.
IL-13 is thought to mediate the effector phase of asthma by
inducing airway remodeling and hyperresponsiveness as well
as mucus hyperproduction (Wills-Karp, 2004). Whereas baso-
phils, mast cells, and eosinophils, which can produce some
Th2 cell-type cytokines, are found in the lungs of asthma patients
(Voehringer et al., 2006), Th2 cells are generally thought to be the
critical source of those cytokines (Cohn et al., 2004).
In most mouse models that simulate asthma, T cells are first
sensitized by allergens such as ovalbumin (OVA) to induce a
Th2 cell-polarized response; sensitizedmice are then challenged
by intranasal administration of the same allergen, resulting in
cytokine production by Th2 cells recruited to the lung and eosin-
ophilic inflammation (Kim et al., 2010). Although these mouse
models have clearly indicated the importance of Th2 cells in
lung inflammation, recent studies have revealed that innate cells
also play a substantial role in asthma. Lung epithelial cells can
produce multiple cytokines in response to stress, including
IL-25, IL-33, and thymic stromal lymphopoietin (TSLP), which
induce Th2 cell-type cytokine production and eosinophilic lung
inflammation. Intranasal administration of IL-25 reproduces
many asthma symptoms (Hurst et al., 2002), and OVA-induced
allergic airway inflammation is inhibited by IL-25 antibody (Bal-
lantyne et al., 2007). It is thought that IL-25 stimulates natural
killer (NK) T cells, which express the IL-25 receptor (IL-17RB)
(Terashima et al., 2008). IL-33 acts on mast cells and basophils
(Schmitz et al., 2005; Schneider et al., 2009). Activated basophils
produce IL-4 and TSLP, which promote Th2 cell-type responses.
IL-33 antibody inhibits eosinophilic lung inflammation, indicating
the importance of IL-33. TSLP activates dendritic cells (DCs) and
enhances the Th2 cell-type response (Ziegler and Artis, 2010).
These epithelial cell-derived cytokines are thought to promote
Th2 cell-type responses and induce lung inflammation.
However, intranasal administration of IL-25 or IL-33 induces
lung eosinophilia in recombinase activating gene (RAG)-deficient
mice, which lack all T and B cells, indicating that an innate cell
population is capable of inducing lung inflammation (Hurst
et al., 2002; Kondo et al., 2008).
Recently, novel innate lymphocytes termed multipotent
progenitor (MPP) type 2, natural helper cells, and nuocytes
have been discovered in the gut-associated mucosa tissues
(Moro et al., 2010; Neill et al., 2010; Saenz et al., 2010b).Immunity 36, 451–463, March 23, 2012 ª2012 Elsevier Inc. 451
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Figure 1. Lung Contains Lin–Sca-1+c-kit+/loCD127+CD25+ Cytokine-Secreting Cells
(A) Gating strategy for identifying LNH (LinSca-1+c-kit+/loCD127+CD25+) cells in naive B6 mouse lungs by flow cytometer is illustrated. The numbers in the plots
indicate the percentages of cells in the indicated gates.
(B) Total numbers per whole naive B6 mouse lung and the percentages of LinSca-1+c-kit+CD127+CD25+ (DP) or LinSca-1+c-kit+CD127CD25 (DN) cells
among lung lymphocytes are shown.
(C) Flow cytometry-purified lung DP and lung DN cells (3.5 3 103 cells in 200 ml media per well) were stimulated with PMA plus ionomycin (P/I) for 3 days, and
cytokines in culture supernatants were measured by ELISA. Unstimulated negative control (neg) for IL-3 is also shown.
Data are representative of three independent experiments (mean and SEM in B, C). See also Figure S1.
Immunity
Lung Natural Helper Cells and Lung InflammationPhenotypically, these cells do not expressmature hematopoietic
lineage markers (Lin) and produce Th2 cell-type cytokines
when stimulated by IL-25 or IL-33. They have been implicated
in immune responses in the gut against helminth infections and
allergens. Similar Lin cells that produce IL-4 and IL-13 have
also been found in other tissues, including the liver, spleen,
and lung via IL-4 reporter and IL-13 reporter mice (Price et al.,
2010). The detection of those cells in the lung is dependent on
the expression of reporter fluorescent proteins, which are
induced by IL-25 stimulation. The finding of Th2 cell-type cyto-
kine-producing innate lymphocytes has led to speculations
that they may play a role in lung eosinophilic inflammation and
asthma (Kaiko and Foster, 2011; Kim et al., 2010; Lloyd and
Hessel, 2010). However, IL-4-eGFP+ cells are barely detectable
in naive mouse lung, and even after stimulation with IL-25 or
Nippostrongylus brasiliensis infection, very few have been de-
tected. Recently, Chang et al. (2011) reported the presence of
LinST2+Sca-1+c-kit+ cells in virus-infected BALB/c mouse
lung and indicated their importance in viral-induced airway
inflammation and macrophage infiltration. Unlike mesenteric
natural helper cells, LinST2+Sca-1+c-kit+ cells do not induce
eosinophil infiltration. Furthermore, their cytokine production
capacity is markedly lower than those of nuocytes and mesen-
teric natural helper cells. Thus, Th2 cell-type cytokine-producing452 Immunity 36, 451–463, March 23, 2012 ª2012 Elsevier Inc.innate lymphocytes in the lung have not been characterized
beyond the initial detection, and their functional significance
remains speculative. Here, we have characterized in detail innate
lymphocytes in normal mouse lungs that rapidly produce
multiple Th2 cell-type cytokines and their regulation in the lung
environment. Further, we demonstrate that these innate lympho-
cytes play a critical role in T cell-independent lung eosinophilia
and mucus hypersecretion induced by protease allergen.
RESULTS
Identification of Lung Natural Helper Cells
in Normal Mice
Flow cytometry analysis of normal B6 mouse lung leukocytes re-
vealed the presence of cells that did not express leukocyte
lineage cell-surface markers (Lin: CD3ε, CD19, CD11b, Gr-1,
NK1.1, and Ter119) (Figure 1A). The Lin leukocyte population
contained a subpopulation that coexpressed stem cell antigen-
1 (Sca-1) and stem cell factor (SCF) receptor CD117 (c-kit).
These LinSca-1+c-kit+ cells were further divided into two
subsets based on coexpression of IL-2Ra (CD25) and IL-7Ra
(CD127) (Figure 1A). The CD25+CD127+ and CD25CD127
subsets made up 0.35% and 0.55% of lung lymphocytes
(approximately 1.53 104 cells and 2.53 104 cells), respectively,
Immunity
Lung Natural Helper Cells and Lung Inflammationin each 4- to 8-week-old naive B6 mouse lung (Figure 1B). Back-
gating analysis of the lung LinSca-1+c-kit+CD25+CD127+ cells
indicated that they formed a distinct population, although a small
fraction is c-kitlo (Figure S1A available online). When the two
subsets of LinSca-1+c-kit+ cells were purified and stimulated
by a combination of phorbol 12-myristate 13-acetate (PMA)
and ionomycin, the CD25+CD127+ subset produced large
amounts of IL-3, IL-5, and IL-13, more moderate amounts of
IL-17A, and low amounts of IL-4 and IFN-g. In contrast, the
CD25CD127 subset did not produce any detectable amount
of the tested cytokines in response to PMA plus ionomycin (Fig-
ure 1C). Purified LinSca-1+c-kitloCD25+CD127+ cells were also
capable of producing Th2 cell-type cytokines when stimulated
with PMA plus ionomycin (Figure S1B). Thus, the phenotype
and the function of lung LinSca-1+c-kit+/loCD25+CD127+ cells
are similar to those of nuocytes, innate type 2 helper cells, natural
helper cells, andMPP type 2 cells in the gut (Saenz et al., 2010a).
We termed lung LinSca-1+c-kit+/loCD25+CD127+ cells lung
natural helper (LNH) cells.
Characterization of LNH Cells
Further flow cytometry analysis showed that LNH (LinSca-1+
c-kit+/loCD25+CD127+) cells were negative for CD4, CD11c,
NKp46, CD34, and CD122 (not shown), whereas they expressed
the pan-leukocyte marker CD45, CD90.2 (Thy1.2), the IL-33
receptor chain T1/ST2, and the T cell costimulatory molecule
ICOS (Figure 2A), thus excluding CD4+ lymphoid tissue-inducing
(LTi) cells, CD11c+ dendritic cells (DCs), NKp46+ NK cells, CD34+
mast cells, and immature hematopoietic progenitors. LNH cells
were similar in morphology to resting lymphocytes, having
a small, round shape with a high nuclear to cytoplasm ratio (Fig-
ure 2B). Analysis of other primary and secondary immune organs
showed that LinSca-1+c-kit+/loCD25+CD127+ cells were barely
detectable in the bone marrow, lymph node, spleen, and blood
(Figure 2C). Furthermore, no LinSca-1+c-kit+/loCD25+CD127+
cells were detected in peribronchial lymph nodes in naive B6
mice (data not shown), indicating that LNH cells are resident
lung lymphocytes. LNH cells were present in Rag1/ and non-
obese diabetic-severe combined immunodeficient (NOD-SCID)
mice, which are deficient for T and B cells, but they are absent
in Rag2/Il2rg/ and NOD-SCID Il2rg/ mice (Figure 2D).
The percentage of LNH cells in wild-type (WT) and Rag1/
mice were similar (Figure S2A). Furthermore, CD25 was
almost exclusively expressed on LNH cells in Rag1/ mice
(Figure S2B). Therefore, LNH cells in Rag1/ mice could be
identified by CD25 staining alone. Purified LNH cells from
Rag1/ mice were functionally competent, secreted Th2 cell-
type cytokines when stimulated in vitro (Figure S2C), and
produced similar amounts of cytokines as didWT LNH cells (Fig-
ure S2D). Although the phenotype of LNH cells was similar to that
of early hematopoietic progenitors and gut MPP type 2 cells,
LNH cells did not form myeloid cell colonies in vitro and did
not differentiate into T, B, or NK cells in the lymphoid differentia-
tion cultures on OP9/OP9-DL1 stroma (Figures S2E–S2H).
Culture of LNH cells on OP9 stroma with IL-2 or IL-7 supported
survival and maintenance of cell-surface phenotype, but not
expansion, and transplanted LNH cells also failed to engraft or
differentiate into T, B, or NK cells in NOD-SCID Il2rg/ recipient
mice (data not shown).Gene Expression Profile of LNH Cells
To further characterize LNH cells, the global gene expression
patterns of purified LNH cells before and after stimulation with
PMA plus ionomycin were analyzed by Affymetrix microarray.
The gene expression profile of resting LNH cells differed from
those of lung macrophages, lung DCs, CD4 T cells, NK cells,
gdT, and regulatory T cells (Figure 3A). LNH cells expressed
high amounts of Gata3, Cd69, Il2ra, and Rora and low amounts
of Notch1 and Rorc transcripts. As expected from the flow
cytometer analysis, LNH cells expressed high amounts of the
c-kit (kit), CD127 (Il7r), and CD25 (Il2ra) transcripts. They also
expressed the genes encoding the receptors for IL-2 (Il2ra and
Il2rg), IL-4 (Il4ra), IL-25 (Il17rb), and IL-33 (Il1rl1). However, the
Il1rap gene encoding the other chain of the IL-33 receptor was
not highly expressed in LNH cells. Stimulation of LNH cells
with PMA plus ionomycin induced upregulation of IL-3 (Il3),
IL-4 (Il4), IL-17A (Il17a), and IL-17F (Il17f) transcripts (Figure 3B).
Unstimulated LNH cells expressed the IL-5 gene (Il5), and it was
only slightly upregulated by the stimulation with PMA plus iono-
mycin, whereas the IL-33R (Il1rl1) and IL-25R (Il17rb) transcripts
were downregulated by the stimulation.
Cytokine-Mediated Stimulation of LNH Cells
LNH cells were purified and cultured in the presence of various
combinations of cytokines, including IL-2, IL-3, IL-4, IL-7,
IL-15, IL-25, IL-33, TSLP, stem cell factor (SCF), and Fms-like
tyrosinekinase ligand (Flt3L). The flow cytometer and microarray
analysesmentioned above showed that LNH cells expressed the
receptors for IL-2, IL-4, IL-7, and IL-25, whereas IL-33 has been
reported to be important in stimulating other innate helper cells.
Unlike gut natural helper cells, which readily respond to IL-2,
IL-7, and IL-33 alone (Moro et al., 2010), purified LNH cells
produced only low levels of Th2 cell-type cytokines in response
to IL-33 alone (Figure 4A). Although IL-33 is required, costimula-
tion with other cytokines was critical in the activation of purified
LNH cells. Combinations of IL-33 and IL-2, IL-7, or TSLP resulted
in very large amounts of IL-5 (>0.4 pg/cell) and IL-13 (1.5 pg/
cell) production. IL-25 failed to activate LNH cells by itself or
with IL-33 but enhanced IL-13 production by LNH cells stimu-
lated with IL-33 plus IL-7. IL-7 had a dampening effect on
IL-33 plus TSLP stimulation. None of the cytokine combinations
induced IL-3, IL-4, or IL-17A production from purified LNH cells
(data not shown).
Because the activation of LNH cells might require factors
derived from the lung microenvironment, we employed lung
explant cultures, which mimic the physiological state of the
lung in vivo (Henjakovic et al., 2008). Freshly isolated lungs
were cut into slices of approximately 0.5 mm thickness and
cultured in vitro with cytokines, and the amounts of IL-17A,
IL-5, and IL-13 secreted into the media were measured. IL-25
alone or IL-2 plus IL-7 readily induced IL-5 and IL-13 (Figure 4B)
secretion by the lung explants prepared from WT and Rag1/
mice, which have LNH cells but no B, T, or NKT cells. In contrast,
Rag2/Il2rg/ mouse lung explants, which have no LNH cells
or other lymphocytes, did not secrete significant amount of
IL-13 or IL-5 upon stimulation with cytokine or PMA plus ionomy-
cin (Figures S3A and S3B). The production of IL-5 was rapid, and
substantial amounts of IL-5 were secreted even in unstimulated
cultures, although IL-25 alone and IL-2 plus IL-7 significantlyImmunity 36, 451–463, March 23, 2012 ª2012 Elsevier Inc. 453
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Figure 2. Characterization of LNH Cells
(A) Surface expression of indicated molecules on lung LinSca-1+c-kit+/loCD127+CD25+ cells (black line histograms) and control cells (shaded gray histograms)
was analyzed by flow cytometry. For CD45 and CD34 staining, BM cells were used as control. For all others, spleen cells were used as control.
(B) The morphology of flow cytometry-purified LNH cells were examined by Diff-Quick staining. Scale bar represents 25 mm.
(C) Bone marrow (BM), lymph node (LN), spleen (SP), blood (BL), and lung cells were analyzed by flow cytometry for LNH cells. Live (DAPI) lymphocytes (FSC/
SSC) were first gated, and Lin cells were then gated for the analysis of c-kit and Sca-1 expression. LinSca-1+c-kit+ cells were gated as indicated by red boxes
(top) and further analyzed for CD25 and CD127 expression (bottom). The numbers in the plots indicate the mean percentages (upper) and SEM (lower in italic) of
cells in the gates and quadrants, calculated from three independent analyses.
(D) LinSca-1+c-kit+/lo cells in B6 (WT) and indicated mouse strains (n = 4) were analyzed for the expression of CD25 and CD127.
Data are representative of at least three independent experiments. Numbers in flow cytometry plot are mean (top) and SEM (below in italics). See also Figure S2.
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Figure 3. Gene Expression Analysis of LNH Cells
(A) Flow cytometry-purified LNH cells were analyzed for
gene expression by Affymetrix microarray. The expression
of the indicated genes in LNH cells (triplicate experiment)
were compared to available microarray results (duplicates)
of other known leukocyte lineages.
(B) Flow cytometry-purified LNH cells were stimulated with
PMA plus ionomycin for 12 hr and analyzed for gene
expression by microarray. The expression of the indicated
genes in stimulated LNH cells (duplicates) were compared
to those of nonstimulated samples (triplicates).
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Lung Natural Helper Cells and Lung Inflammationincreased the amount of IL-5 production. This was consistent
with the microarray analysis above, which showed high baseline
expression of the IL-5 transcript in LNH cells (Figure 3A). IL-33
did not enhance IL-5 or IL-13 production above the PBS control.
None of the tested conditions except PMA and ionomycin re-
sulted in secreted IL-17A from LNH cells in explant cultures
(data not shown). Intracellular cytokine staining of lung explants
confirmed that CD25+ cells in Rag1/ mice were the main
producers of IL-5 (Figure 4C). Because LNH cells were the only
CD25+ cells in the lungs of Rag1/ mice, those results showed
that IL-25 or IL-2 plus IL-7 stimulate LNH cells and induce the
production of IL-5 and IL-13 in lung explant cultures. Costaining
for intracellular IL-17A and IL-5 in Rag1/ mouse explants
stimulated with PMA plus ionomycin showed that some LNH
cells produced both IL-5 and IL-17A whereas other LNH cells
produced one or the other cytokine but not both (Figure 4D).
Thus, LNH cells are the major source of IL-5 and IL-13 in cyto-
kine-stimulated lungs. Although a small subset of LNH cells is
also capable of producing IL-17A, physiological stimuli that
induce IL-17A production by LNH cells are currently unknown.
LNH Cells Are Responsible for Papain-Induced
Eosinophilia and Mucus Secretion
in RAG1-Deficient Mice
Papain is a protease known to cause occupational asthma
(Novey et al., 1979). It also causes asthma-like symptoms in
RAG-deficient mice (Oboki et al., 2010). Therefore, we tested
whether LNH cells are involved in papain-induced lung inflam-
mation. Intranasal administration of papain (Figure S5A) into
WT and Rag1/ mice, which have LNH cells, and into Rag2/
Il2rg/ mice, which have no LNH cells, showed striking differ-
ences among those mice. Eosinophil counts in bronchioalveolar
lavage (BAL) were significantly elevated in papain-stimulated
WT and Rag1/ mice, compared to Rag2/Il2rg/ mice
(Figure 5A). Tissue-infiltrating eosinophils were also increased
in papain-stimulated WT and Rag1/ mice but not Rag2/
Il2rg/ mice (Figure 5B). Histological analysis of lung sectionsImmunity 36, 4mirrored our flow cytometry findings, showing
eosinophilia detected only in lungs of WT and
Rag1/ mice treated with papain (Figure S4B).
Furthermore, BAL levels of IL-5 and IL-13 were
significantly increased in papain-treated WT
and Rag1/ mice, but not Rag2/Il2rg/
mice (Figure 5C). Periodic acid-Schiff (PAS)
staining of mucus in papain-treated lungs also
showed mucus production from airway gobletcells in WT and Rag1/mouse lungs, whereas Rag2/Il2rg/
mouse lungs showed no mucus production (Figure 5D). Similar
results were obtained with NOD-SCID and NOD-SCID Il2rg/
mice, mirrored by increased serum concentration of IL-5 in WT
and NOD-SCID but not NOD-SCID Il2rg/ mice (Figure S4C).
To further investigate the role of LNH cells in T cell-indepen-
dent lung inflammation, we depleted LNH cells from Rag1/
mice by CD25 antibody injection (Figure S5A). LNH cells identi-
fied by CD127 and CD25 (stained by different mAb) expression
were barely detectable in the treated mice (Figure 6A). LNH
cell-depleted mice showed a significant decrease in allergen-
induced eosinophilia (Figure 6B). Histological analysis also
showed that LNH cell depletion significantly inhibited lung eosin-
ophilia in papain-treated Rag1/mice (Figure 6C). PAS staining
showed decreased mucus production in LNH cell-depleted
Rag1/mouse lungs (Figure 6D). Similar results were observed
in mice stimulated with house dust mite (HDM) extract (Figures
S5C and S5D) or IL-25 (Figures S5E–S5G). In addition to deple-
tion, we also transplanted LNH cells into Rag2/Il2rg/ mice,
followed by papain stimulation (Figure S5B). Transplanted LNH
cells were detectable inRag2/Il2rg/mouse lungs (Figure 6E)
and promoted allergen-induced eosinophilia (Figure 6F).
Enhanced mucus production was also observed in papain-stim-
ulated Rag2/Il2rg/ mouse lungs after LNH cell transplant
(Figure 6G). Thus, LNH cells are critical for papain-induced
lung eosinophilia and mucus hyperproduction.
Papain Stimulation Enhances Th2 Cell-type Cytokine
Production from LNH Cells
IL-5 and IL-13 are known to drive eosinophil maturation and
infiltration, goblet cell hyperplasia, and mucus secretion. To
investigate the role and regulation of LNH cells in response to
papain, we stimulated lung explants from WT, Rag1/, and
Rag2/Il2rg/ mice and assessed IL-25, IL-33, TSLP, IL-5,
and IL-13 production by ELISA. Papain induced IL-5 and IL-13
secretion in WT and Rag1/ but not in Rag2/Il2rg/ mouse
lung explant cultures (Figures 7A and 7B), consistent with the51–463, March 23, 2012 ª2012 Elsevier Inc. 455
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Figure 4. LNH Cells Rapidly Produce Th2 Cell-type Cytokines in Response to IL-33 plus Costimulation
(A) Purified LNH cells (1.0 3 103 cells in 200 ml media per well) were stimulated with cytokines or PMA plus ionomycin (P/I) as indicated for 3 days, followed by
ELISA analysis for IL-5 and IL-13 in culture supernatants.
(B) Lung explants from indicatedmouse strains were stimulated with cytokines or PBS. The amounts of IL-5 (left) and IL-13 (right) in the culture supernatants were
assayed by ELISA at the times indicated on the x axis.
(C) Rag1/ lung explants were stimulated with IL-25 or PBS for 6 hr, followed by analysis for intracellular IL-5 production. Cells were first electronically gated to
exclude blood cells, debris (FSC/SSC), dead cells, and NK cells (NK1.1). Fluorescence minus one (FMO) staining was used as control. The numbers indicate the
percentages of cells in the quadrant (top) with mean fluorescence intensity of IL-5-positive cells (italicized below).
(D) Rag1/ mouse lung explants were stimulated with P/I or PBS for 12 hr. Explants were processed and surface-stained as in (C) and CD25+ LNH cells were
analyzed for intracellular IL-5 and IL-17A by flow cytometry. Fluorescence minus intracellular stain was used for control. The numbers in the plots show the
percentage of cell in each quadrant.
Data are representative of at least three independent experiments (mean and SEM in A and B). See also Figure S3.
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Lung Natural Helper Cells and Lung Inflammationabove in vivo results. These results also indicate that papain
induces IL-5 and IL-13 production by lung-resident lymphocytes
rather than by recruiting cytokine-producing cells from circula-
tion to the lung. IL-33, IL-25, and TSLP were produced in lung
explant cultures from all mouse strains (Figures 7C–7E). Stimula-
tion with papain caused increased IL-25 and TSLP production.
IL-33 was constitutively produced in lung explant cultures, and
papain stimulation induced a minor but significant increase in
concentration. Neutralization of TSLP and/or IL-33 in papain-
stimulated explants resulted in a significant reduction of IL-5
and IL-13 production (Figures S6A–S6D). Heat-inactivated
papain did not induce cytokine production above PBS levels
(Figure S6E).
Intracellular IL-13 staining of cells in papain-treated Rag1/
mouse lung explant cultures showed that the main producers
of IL-13 in Rag1/ mouse lung explants were CD25+ LNH cells456 Immunity 36, 451–463, March 23, 2012 ª2012 Elsevier Inc.(Figure 7F). Intracellular IL-5 staining of WT and Rag1/ mouse
explants indicated that papain stimulation causes rapid IL-5
production almost exclusively from CD25+ LNH cells and not
fromNK, NKT, or T cells (Figure 7G). Themajority of papain-stim-
ulated LNH cells from WT and Rag1/ mice produced IL-5 but
not IL-13 whereas small fractions produced IL-13 alone or both
IL-5 and IL-13 (Figure 7H). Thus, papain treatment induces
production of cytokines by stroma cells, which in turn stimulate
LNH cells to produce IL-5 and IL-13. The stimulated LNH cell
population is heterogeneous and consists of subsets producing
IL-5, IL-13, and both.
DISCUSSION
We have identified LinSca-1+c-kit+/loCD25+CD127+ cells in
naive B6 mouse lung and termed them LNH cells. They have
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Figure 5. LNH Cells Are Required for T Cell-Independent Eosinophil Infiltration and Mucus Secretion in Papain-Induced Lung Inflammation
(A) Bronchioalveolar lavage (BAL) cells from mice treated with heat-inactivated papain (white) or papain (black) were identified by flow cytometry and quantified.
(B) Leukocytes from whole lung tissue from mice treated with heat-inactivated papain (white) or papain (black) were analyzed by flow cytometry and quantified.
(C) BAL fluid from heat-inactivated papain- (white) or papain- (black) treated mice was analyzed for IL-5 (top) and IL-13 (bottom) concentration by ELISA.
(D) Mucus secretion from heat-inactivated papain- (control) or papain-treated mice was analyzed by PAS staining of formalin-fixed paraffin-embedded lung
sections.
Scale bars represent 50 mm. *p < 0.05, **p < 0.001 (two-tailed Student’s t test). Data are representative of three independent experiments (mean and SEM in A, B,
and C). See also Figure S4.
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Lung Natural Helper Cells and Lung Inflammationthe capacity to rapidly produce large amounts of Th2 cell-type
cytokines, and they are critical for induction of eosinophilic
lung inflammation by protease allergens, which are known to
cause asthma in humans. Whereas T cells are thought to be
important for asthma in general, papain has been shown to
induce asthma-like symptoms in RAG-deficient mice, indicating
the presence of a T cell-independent mechanism. We have
demonstrated that intranasal administration of papain into
Rag1/ mice, but not Rag2/Il2rg/ mice, rapidly causes
lung eosinophilia, mucus hypersecretion, and elevation in BAL
IL-5 and IL-13 levels. LNH cells are present in the former mice
but absent in the latter. Furthermore, depletion of LNH cells inRag1/ mice by CD25 mAb injection significantly reduces
lung eosinophilia and mucus secretion upon papain administra-
tion. Conversely, adoptive transplant of LNH cells into Rag2/
Il2rg/ mice reconstitutes these symptoms, thus providing
convincing evidence that LNH cells are critical in T cell-indepen-
dent allergic lung inflammation. Indeed, LNH cells are the main
source of IL-5 and IL-13 in both Rag1/ and WT lung explant
cultures treated with papain. Taken together, those results
suggest that LNH cells are a critical early source of IL-5 and
IL-13 in protease allergen-induced lung inflammation. HDM is
another allergen known to depend largely on protease activity
(Gregory and Lloyd, 2011). Our results show that LNH cells canImmunity 36, 451–463, March 23, 2012 ª2012 Elsevier Inc. 457
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Figure 6. LNH Cell Depletion and Adoptive Transplant Show that LNH Cells Are Required for Papain-Induced Mucus Production and Eosin-
ophil Infiltration
(A) LNH cells were depleted by intraperitoneal injection of CD25mAb (clone PC61 5.3) intoRag1/mice. Two days later, lung lymphocytes were stainedwith Lin-
cocktail mAb, CD25 (clone 7D4), and CD127 mAb and analyzed by flow cytometer to confirm LNH cell depletion. The numbers in the plots show the percentages
of cells in the indicated gates.
(B) Rag1/ mice were nondepleted and treated with papain (black), LNH depleted and treated with papain (striped), or nondepleted and treated with heat-
inactivated papain (white), and leukocytes in BAL and lung tissue were analyzed by flow cytometry and quantified.
(C) Eosinophils were quantified in H&E-stained lung sections of papain- (black) or heat-inactivated papain- (white) treated depleted and nondepleted Rag1/mice.
(D) Mucus secretion was analyzed by PAS staining of formalin-fixed paraffin-embedded lung sections of heat-inactivated papain- (control) or papain-treated,
LNH-depleted, and nondepleted Rag1/ mice. Scale bars represent 50 mm.
(E) In vitro expanded purified LNH cells were intravenously injected (53 104 cells per mouse) into Rag2/Il2rg/mice, and lymphocytes in the recipient mouse
lungswere analyzed by flow cytometry 24 hr after adoptive transplant. Live, LinSca-1+c-kit+/lo cells were first gated and analyzed for cells expressing CD127 and
CD25. Top plot shows control without LNH injection, and bottom plot shows lung lymphocytes of mice injected with LNH cells. The numbers in the plots indicate
the percentage of cells in each quadrant.
(F) BAL and lung tissue of Rag2/Il2rg/ + papain- (black), Rag2/Il2rg/ + LNH cell + papain- (striped), or Rag2/Il2rg/ + LNH cell + heat-inactivated
papain- (white) treated mice were analyzed by flow cytometry and quantified.
(G) Mucus secretion in lungs was analyzed by PAS staining of papain-treated Rag2/Il2rg/mice with or without transplanted LNH cells. Scale bars represent
50 mm, magnified image taken with 403 objective.
*p < 0.05 (two-tailed Student’s t test). Data are representative of at least three independent experiments (mean and SEM in B, C, and F). See also Figure S5.
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Figure 7. LNH Cells Respond to Lung Stroma-Derived Cytokines and Are the Main Producers of IL-5 and IL-13 after Papain Treatment
(A–E) Lung explants of indicated mouse strains were stimulated with papain (black) or PBS (white). The amount of indicated cytokine in the culture supernatants
were assayed by ELISA at the times indicated on the x axis.
(F) Rag1/ lung explants were cultured for 18 hr with PBS or papain and analyzed for intracellular IL-13 and surface expression of CD25. Cells were first
electronically gated to exclude blood cells and debris (FSC/SSC), dead cells, and NK cells (NK1.1). FMO (minus anti-IL-13 staining) of papain-treated explants is
also shown (control).
(G) Rag1/ and WT mouse lung explants were stimulated with papain for 12 hr and analyzed for intracellular IL-5 by flow cytometry. IL-5-producing cells were
gated and analyzed for surface expression of CD3 and NK1.1 (below). Cells were first electronically gated to exclude blood cells and debris (FSC/SSC) and dead
cells. FMO was used as a negative control.
(H) Costaining for intracellular IL-5 and IL-13 inRag1/ andWTmouse lung. Lung explants were stimulated with papain for 18 hr and analyzed by flow cytometry.
CD25+ cells were gated (top) and analyzed for intracellular IL-5 and IL-13 (bottom). Cells were first electronically gated to exclude blood cells and debris
(FSC/SSC), dead cells and NK (NK1.1), and T (CD3) cells. Fluorescence minus intracellular stain was used as a negative control.
*p < 0.05 (two-tailed Student’s t test). Data are representative of at least three independent experiments (mean and SEM in A–E). See also Figure S6.
Immunity
Lung Natural Helper Cells and Lung Inflammationplay an important role in mediating a rapid Th2 cell-type
response to HDM exposure.
Proteases are important components of many allergens (Reed
and Kita, 2004) and thought not only to disrupt mucosa integritybut also to act on protease-activated receptors and activate
airway epithelial cells (Thompson et al., 2001). Activated epithe-
lial cells produce a range of cytokines including TSLP, IL-25, and
IL-33 (Strickland et al., 2010). Our current study has shown thatImmunity 36, 451–463, March 23, 2012 ª2012 Elsevier Inc. 459
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Lung Natural Helper Cells and Lung Inflammationpapain-treated lung explants produce IL-25 and TSLP, whereas
IL-33 production is enhanced upon papain stimulation. IL-33 is
known to be constitutively expressed in endothelial and epithelial
cells and is released as an alarmin upon cell damage (Moussion
et al., 2008). IL-33 has also been detected in naive mouse
lungs (Oboki et al., 2010), which explains the low levels of
IL-33 detected in unstimulated lung explant cultures in our study.
Neutralization of IL-33 in explant cultures significantly decreases
Th2 cell-type cytokine production, and simultaneous neutraliza-
tion of TSLP and IL-33 effectively blocks IL-13 production. This is
consistent with a previous study by Oboki et al. (2010) showing
that papain-induced lung eosinophilia is IL-33 dependent.
Purified LNH cells are stimulated by a combination of IL-33
and TSLP and secrete very large amounts of IL-5 and IL-13.
Therefore, lung stroma-derived IL-33 and TSLP probably
stimulate LNH cells and induce IL-5 and IL-13 production in
papain-treated lungs, resulting in lung eosinophilia, goblet cell
hyperplasia, and mucus production. Interestingly, unstimulated
LNH cells express IL-5 transcript and have intracellular IL-5,
although purified LNH cells do not secrete IL-5 without stimula-
tion. Thus, LNH cells seem to be poised to respond to cytokines
produced by activated lung stromal cells and rapidly release
preexisting IL-5.
Intranasal administration of IL-25 or IL-33 is known to induce
lung eosinophilia in RAG-deficient mice (Hurst et al., 2002;
Kondo et al., 2008). We now have demonstrated that intranasal
IL-25 stimulates LNH cells, resulting in Th2 cell-type cytokine
production and eosinophil infiltration. IL-33 is also critical for
the stimulation of purified LNH cells, although it requires an addi-
tional cytokine, IL-2, IL-7, or TSLP, for efficient stimulation of
LNH cells in vitro. In contrast, IL-25 on its own or in combination
with other cytokines does not stimulate purified LNH cells
although it enhances IL-13 production by LNH cells stimulated
by IL-33 plus IL-7. On the other hand, RAG-deficient mouse
lung explants are stimulated by IL-25 alone, but not IL-33. Base-
line production of IL-33 in the explant cultures explains why
exogenous IL-33 does not stimulate lung explants and why
lung explants produce low levels of IL-5 without additional
cytokines, because IL-33 neutralization inhibits IL-5 and IL-13
secretion. However, how IL-25 alone stimulates mouse lung
explants or LNH cells in vivo is still unknown. It is possible that
IL-25 promotes the production of IL-7 or TSLP by stromal cells,
which in combination with IL-33 stimulates LNH cells in the
explants cultures. Indeed, neutralization of IL-33 and TSLP
inhibits cytokine production by LNH cells in lung explant cultures
stimulated by IL-25. Alternatively, the lung microenvironment
may provide cell-surface ligands that participate in LNH cell
stimulation. LNH cells express the T cell costimulatory receptor
ICOS and also express the transcript for 4-1BB (data not shown),
but their functional significance is currently unknown.
The phenotype and the function of LNH cells are similar to
those of recently discovered innate helper cells (termed MPP
type 2), natural helper cells (Moro et al., 2010), nuocytes, and
innate type 2 helper cells (Saenz et al., 2010a). MPP type 2 cells
were detected by the expression of GFP in IL-4-eGFP reporter
mice stimulated with IL-25 (Saenz et al., 2010b). They are
LinSca-1+c-kitint, but unlike LNH cells, they do not express
CD127 (Saenz et al., 2010a). Furthermore, Il4 transcript is absent
in unstimulated LNH cells and no IL-4 is secreted from cytokine-460 Immunity 36, 451–463, March 23, 2012 ª2012 Elsevier Inc.activated LNH cells, although the most striking difference is
that MPP type 2 have progenitor capacity and can differentiate
into myeloid cells, whereas no progenitor activity is detected
with LNH cells. As such, MPP type 2 cells probably constitute
an entirely separate lineage. Innate type 2 helper cells were
also identified in IL-4-eGFPmice and were found in naive mouse
mesenteric LN, spleen, and liver. They are also Lin, but Sca-1,
CD122lo, heterogeneous for c-kit expression, and express high
baseline Il4 transcript, unlike LNH cells (Price et al., 2010). It
should be noted that LNH cells do not produce detectable level
of IL-4 upon stimulation with cytokine combinations or papain-
treated lung explant cultures. Nuocytes were identified in the
mesenteric LN and spleen of IL-13-eGFP mice upon induction
by IL-25 or IL-33 administration or helminth infection (Neill
et al., 2010). The phenotype of nuocytes (LinSca-1+c-kit+
CD127+ICOS+) is similar to that of LNH cells. Functionally, nuo-
cytes produce IL-5 and IL-13, but differ from LNH cells in their
secretion of substantial amounts of IL-6. Natural helper cells
found in fat associated lymphoid cluster (FALC) in the mesentery
are LinSca-1+c-kit+CD25+CD127+ and also produce IL-6 in
addition to IL-5 and IL-13 when stimulated (Moro et al., 2010).
Thus, LNH cells, nuocytes, and FALC natural helper cells are
similar to each other and they probably belong to the same
innate lymphocyte lineage, although differences in cytokine
production capacity and some cell-surface markers are evident.
Most notably, IL-6 is not produced by LNH cells although IL-17A
is. It is possible that the differences are partly due to different
ways of identifying those cells. MPP type 2, nuocytes, and innate
type 2 helper cells were identified by the reporter eGFP expres-
sion upon stimulation or helminth infection, and thus probably
are activated cells and might have migrated into the affected
tissue, whereas FALC natural helper cells and LNH cells were
identified in naivemice and probably are unstimulated and tissue
resident. It is also possible that they may be in different stages of
development in the same cell lineage. Alternatively, their pheno-
types and functionsmay be influenced by themicroenvironment,
as indicated by the fact that they are located in different anatom-
ical sites.
The recently described LinST2+Sca-1+c-kit+ cells, also
termed natural helper cells, in BALB/c mouse lungs have been
shown to play a role in influenza virus-induced airway hyperreac-
tivity (Chang et al., 2011). Although LinST2+Sca-1+c-kit+ cells
may partially overlap with LNH cells in our study, significant
differences in phenotype and function are also apparent. Most
strikingly, LinST2+Sca-1+c-kit+ cells are far less efficient in
Th2 cell-type cytokine production than LNH cells. Purified
LinST2+Sca-1+c-kit+ cells (4 3 104 cells per well) stimulated
with IL-33 plus IL-2 produce less than 500 pg/ml IL-13 and
less than 125 pg/ml IL-5 whereas purified LNH cells (103 cells
per well) stimulated in the same way produce almost 4 ng/ml
IL-13 and >2 ng/ml IL-5. In fact, it is unclear whether LinST2+
c-kit+Sca-1+ cells in BALB/c mouse lungs are the major source
of Th2 cell-type cytokines upon influenza virus infection; lung
macrophages also produce significant levels of IL-13, with at
least 12,500 IL-13+ macrophages per lung, compared to 200
LinST2+Sca-1+c-kit+ cells. The inability to produce a significant
amount of IL-5 probably explains why lung LinST2+Sca-1+
c-kit+ cells do not induce eosinophilic lung inflammation, even
upon adoptive transplantation of in vivo expanded cells at
Immunity
Lung Natural Helper Cells and Lung Inflammation2,000 times more than naive cell numbers per animal. Eosino-
philic inflammation induced by IL-5 is a hallmark Th2 cell
response, and the lack of eosinophilia in influenza virus infection
suggests that LinST2+Sca-1+c-kit+ cells are unlikely to be
involved in Th2 cell-mediated lung inflammation. Furthermore,
viral infection did not appear to stimulate IL-13 production
from LinST2+Sca-1+c-kit+ cells because artificial stimulation
with PMA plus ionomycin was required. It is possible that viral
infection may induce macrophage IL-33 production and prime
LinST2+Sca-1+c-kit+ cells in BALB/c mice. In our study, LNH
cells are the main, if not the only, source of IL-5 and IL-13 in
papain-treated Rag1/ mouse lungs as indicated by intracel-
lular cytokine staining as well as depletion of LNH cells. Deple-
tion of LinST2+Sca-1+c-kit+ by anti-CD90.2 injection results in
significant decrease in virally induced airway hyperreactivity in
Rag2/ mice, but the effect is complicated by the presence of
other CD90-positive cells in the lung, most notably NK cells
(Koo et al., 1980), which respond to viral infections (Mandelboim
et al., 2001). Because detailed phenotypic analysis of LinST2+
c-kit+Sca-1 population is lacking, it is difficult to directly
compare the two populations. Nevertheless, the inefficient Th2
cell-type cytokine production by LinST2+Sca-1+c-kit+ cells
clearly separates them from LNH cells and other innate Th2
cell-type cytokine-producing lymphocytes.
The gene expression profile of LNH cells is very different from
those of lung macrophages and DCs and indicates their distinct
lymphoid origin. Interestingly, LNH cells do not express the Rorc
gene encoding RORg, a member of the ROR family of nuclear
hormone receptors, known to be important for Th17 cells (Ivanov
et al., 2006). The lack of Rorc expression also separates LNH
cells from another family of innate lymphocytes that includes
LTi-like cells and IL-22-producing NK-like cells (Sawa et al.,
2010). Those innate lymphocytes express RORgt, an isoform
of RORg, and produce IL-22.
The lung is a unique immune site because it is constantly
exposed to potential pathogens. Innate lymphocytes that are
capable of rapidly responding to infections are probably impor-
tant for the lung immune system. LNH cells comprise a distinct
population of innate lymphocytes that rapidly respond to lung
epithelium-derived cytokines. Thus, innate lymphocytes in the
lung can be divided into two functionally distinct populations,
namely cytotoxic NK cells and cytokine-producing NH cells,
similar to cytotoxic CD8 T cells and helper CD4+ T cells in the
adaptive immune system.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (WT), NOD-SCID, and NOD-SCID Il2rg/ mice were maintained in
the BCCRC pathogen-free animal facility. B6.Rag1/ mice were purchased
from The Jackson Laboratories. B6.Rag2/Il2rg/ mice were purchased
from Taconic Farms. Mice were used at 4–8 weeks of age. All animal use
was approved by the animal care committee of the University of British
Columbia, and animals were maintained and euthanized under humane
conditions in accordance with the guidelines of the Canadian Council on
Animal Care.
Antibodies, Reagents, Flow Cytometry Sorting, and Analysis
Phycoerythrobilin (PE)-conjugated anti-CD4, CD11c, CD90, CD122, CD127,
FITC-conjugated anti-CD3ε, CD19, NK1.1, Mac-1, Gr-1, Ter119, MHCII,
CD45.2, Allophycocyanin (APC)-conjugated anti-CD117, IL-5, CD25, Alexa647-conjugated anti-CCR3, PerCP-cy5.5 conjugated anti-CD25, NK1.1,
CD3, B220, and PE.cy7-conjugated Sca-1 were purchased from BD Biosci-
ences, and PE-conjugated anti-NKp46, ICOS, IL-5, and IL-13 was purchased
from eBioscience. FITC-conjugated anti-T1/ST2 was purchased from MD
Bioproducts. Propidium iodide (PI), eFluor 780 (eBioscience), or DAPI reagents
were used to exclude nonviable cells. IL-2, IL-7, IL-25, IL-33, SCF, and TSLP
were purchased from eBiosiences, IL-4 was purchased from STEMCELL
Technologies, and PMA and ionomycin were purchased from Sigma Aldrich.
Polyclonal goat anti-mouse IL-33 IgG was purchased from R&D Systems.
BD Caliber (Cytek 6 color upgrade) and Canto II were used for phenotypic
analysis, BD FACS Aria II was used for cell sorting and phenotypic analysis,
and Flowjo v. 8.6 was used for data analysis.
Primary Leukocyte Preparation
Cell suspensions were prepared from lung, spleen, LN, blood, or BM tissue as
described (Veinotte et al., 2008).
Isolation of LNH Cells
Lung cells were incubated with 2.4G2 to block Fc receptors and then stained
with FITC-conjugated lineagemarker mAbs (CD3, CD19, NK1.1, Mac-1, GR-1,
and Ter119), PE-CD127, PE.cy7-Sca-1, PerCP-cy5.5-CD25, and APC-CD117
and purified by flow cytometry.
Cytokine Production Assay
Flow cytometry-purified B6 or Rag1/ mouse LNH cells were cultured in
200 ml RPMI-1640 media containing 10% FBS, penicillin and streptomycin
(P/S), and 50 mM 2-mercaptoethanol (2ME) at 37C. Cells were stimulated
with IL-25 (10 ng/ml), PMA (30 ng/ml) and ionomycin (500 ng/ml), IL-2
(1000 U/ml), IL-7 (10 ng/ml), TSLP (10 ng/ml), and IL-33 (10 ng/ml).
Lung Explant Culture
Mice were sacrificed by CO2 asphyxiation. Lungs were instilled via 18G cath-
eter with 1.5 ml 1% low melting point agar in RPMI-1640 + 10% FCS, 2-ME,
P/S at 37C and cooled on ice. Lungs were sliced by razor into 0.5 mm thick
sections placed in 2 ml RPMI-1640, 10% FCS, 2ME, P/S, and stimulated with
IL-25 (10 ng/ml), PMA (30 ng/ml) and ionomycin (500 ng/ml), papain (10 mg/ml),
IL-2 (1000 U/ml), and IL-7 (10 ng/ml). Lung explants from one animal were
divided into six separate cultures; total cell number per culture was counted
to allow normalization of ELISA data. For intracellular cytokine staining, Golgi-
Plug (BD Biosciences) was added to the lung explant cultures 6 hr before
collection, and lung explants were passed through a 70 mm filter to make
single-cell suspension.
Intracellular Staining
Intracellular staining for IL-17A, IL-5, and IL-13 was performed with the Cyto-
fix/Cytoperm Plus kit (BD Biosciences) according to the manufacturer’s
protocol. Dead cells were stainedwith eFluor 780 (eBioscience) fixable viability
dye before fixation/permeabilization and were gated out during analysis.
ELISA Assay
IFN-g, IL-5, IL-6, IL-12, IL-13, IL-17A, IL-25, IL-33, TSLP (eBioscience), IL-4
(R&D Systems), and IL-3 (BD Bioscience) ELISAs were performed according
to the manufacturer’s protocol.
RNA Isolation and Microarray
Total RNAwas isolated from flow cytometry-purified unstimulated cells or cells
stimulated for 12 hr with PMA plus ionomycin by Trizol (Invitrogen). Agilent
Bioanalyzer 2100, RNA amplification, andmicroarray services were performed
by McGill University and Ge´nome Que´bec Innovation Centre with the Affyme-
trix Mouse Gene 1.0 arrays. All data analysis was performed with FlexArray
1.5 (Genome Quebec). Microarray data sets for other cells were obtained
from data assembled by the ImmGen consortium (Heng and Painter, 2008).
In Vivo Papain Stimulation, LNH Cell Depletion, and Adoptive
Transplant
For LNH cell depletion, mice were twice injected intraperitoneal every 24 hr
with 200 mg of anti-CD25 produced from PC61 5.3 hybridoma 2 days before
papain stimulation. For LNH cell adoptive transplant, LNH cells were purifiedImmunity 36, 451–463, March 23, 2012 ª2012 Elsevier Inc. 461
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Lung Natural Helper Cells and Lung InflammationfromWTmice by flow cytometry and expanded in IL-25 and IL-33 (10 ng/ml) for
5 days. Expanded LNH cells or PBS control were injected by tail vein on day 0.
Mice were anesthetized by isofluorane inhalation, followed by intranasal injec-
tion of papain or heat-inactivated papain (10 mg) in 40 ml of PBS on days 0–2.
Blood was collected from the tail vein on days 1 and 2 and cardiac puncture on
day 3. Mice were sacrificed on day 3 and lungs and BAL (1 ml PBS) were
collected or airways were instilled with 50:50 Tissue-Tek O.C.T. Compound/
PBS (Adwin Scientific) and fixed in formalin. Lung tissue was processed as
described previously and lung and BAL cells were then counted and identified
by flow cytometry (van Rijt et al., 2004). Fixed lungs were embedded in paraffin
and processed for H&E or PAS staining by the Centre for Translational and
Applied Genomics (Vancouver, Canada).
Statistics
Data were analyzed with GraphPad Prism 5 (GraphPad Software). A Student’s
t test was used to determine statistical significance between groups, with p%
0.05 being considered significant. The statistical analysis of microarray results
was carried out with FlexArray (Genome Quebec).
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